World tennis number one player Novak Djokovic of Serbia will not be able to defend his Australian Open crown after his visa was canceled for a second time by local migration authorities.
An Australian Circuit Court Monday ruled in favor of reinstating tennis' top player Novak Djokovic his visa, which was canceled by immigration officials on the grounds that he was not vaccinated against COVID-19.
Brazilian children aged 5 to 11 will be added to the National Immunization Program against COVID-19, Health Minister Marcelo Queiroga announced Wednesday.
Tennis' number one player Novak Djokovoc was held for eight hours at Melbourne's international airport and later deported for not complying with Australian protocols regarding vaccination against COVID-19 for foreign travelers.
The Serbian Djokovic was to defend his Australian Open title, which he has won 9 timers altogether, including the last three consecutive editions.
The Government of Italy Wednesday issued a decree making COVID-19 vaccination mandatory for all those over the age of 50, it was announced. Out of Italy’s 59 million people, 28 million fall over the age of 50.
The Argentine Province of Buenos Aires, which concentrates most of the country's beach resorts, has announced a Health Pass will be required for people over the age of 13 starting Dec. 21.
Argentina's Health Minister Carla Vizzotti Wednesday announced the country's entire population will receive the booster dose of the COVID-19 vaccine.
The Government of the United States Monday reopened the country's land and air borders Monday to foreign visitors who are vaccinated against COVID-19.
Health Ministers of jurisdictions other than the federal government have lined up together behind their national colleague Carla Vizzotti after the latter was accused of lying when she recommended vaccinating children aged 3 to 11 with Sinopharm.
The World Health Organization (who) has approved the COVID-19 vaccine developed by India's Bharat Biotech laboratory for emergency use, it was announced. The drug is known worldwide under its commercial brand: Covaxin.